Expand PDSB Menu
PDSB MENU

PDSB Latest Press Releases

-- May 13, 2026 --

PDS Biotech Reports First Quarter 2026 Financial Results and Provides Clinical Programs and Corporate Update Globe Newswire 7:00 AM

-- May 6, 2026 --

PDS Biotech Announces Conference Call and Webcast for 2026 First Quarter Financial Results Globe Newswire 8:00 AM

-- April 15, 2026 --

PDS Biotech Announces Publication of Positive PDS01ADC Interim Phase 2 Clinical Trial Data from Stage 1 of NCI-led Metastatic Colorectal Cancer (mCRC) Trial Globe Newswire 8:59 AM

-- March 30, 2026 --

PDS Biotech Reports Full Year 2025 Financial Results and Provides Update on PDS0101 Phase 3 Program and PDS01ADC Clinical Advancement Globe Newswire 7:00 AM

-- March 24, 2026 --

PDS Biotech Announces Conference Call and Webcast for 2025 Fourth Quarter and Year End Financial Results Globe Newswire 4:05 PM

-- February 20, 2026 --

PDS Biotech Announces Adoption of Amended Protocol for Phase 3 VERSATILE-003 Trial Incorporating Progression Free Survival (PFS) as Primary Endpoint for Interim Analysis and Potential Accelerated Approval Globe Newswire 8:30 AM

-- January 28, 2026 --

PDS Biotech Announces Presentation of Preliminary Results from Phase 2 Study of IL-12 Tumor Targeted Immunocytokine (PDS01ADC) in 3rd Line Metastatic Castration Resistant Prostate Cancer by the NCI Globe Newswire 8:45 AM

-- January 22, 2026 --

PDS Biotech Announces New U.S. Patent Covering Technology Underlying PDS0101 Globe Newswire 8:45 AM

-- January 9, 2026 --

PDS Biotech Announces FDA Alignment on use of Progression Free Survival (PFS) as Primary Endpoint Globe Newswire 8:45 AM
Market Data Delayed 15 Minutes